CCT6A expression was shown to be increased in 10 human tumor cell lines and associated with poor survival in lung cancer (Ying et al., 2017), breast cancer (Huang et al., 2019), and glioblastoma (Hallal et al., 2019). Here, CCT6A is linked to lung carcinoma.